Xlife Sciences AG/ CH0461929603 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 157.58 mill.EUR | - | - |
Assets
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | - | - | - | .5350 | .3940 | ||||||
Intangible Assets | - | - | - | 300.9090 | 285.0530 | ||||||
Long-Term Investments | 146.8000 | 180.7000 | 477.6000 | 187.5400 | 208.4130 | ||||||
Fixed Assets | - | - | - | 488.9850 | 493.8751 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 2.4000 | .3000 | .5000 | .5450 | 9.1272 | ||||||
Cash and Cash Equivalents | 2.5000 | 4.7000 | 2 | .2210 | .2187 | ||||||
Current Assets | 5.1000 | 5 | 2.5000 | 1.2450 | 18.1185 | ||||||
Total Assets | 154 | 185.7000 | 480.1000 | 490.2300 | 511.9940 |
Liabilities
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | .4000 | .3000 | .4000 | .6270 | .9720 | ||||||
Long-term debt | 56.2000 | 52.4000 | 158.5000 | 60.2370 | 55.5730 | ||||||
Liabilities to Banks | 56.2000 | 52.4000 | 158.5000 | - | - | ||||||
Provisions | .1000 | 2.7000 | 2 | 90.0760 | .0671 | ||||||
Liabilities | 56.7000 | 55.5000 | 160.8000 | 152.5270 | 146.9570 | ||||||
Share Capital | 3.7620 | 4.1570 | 5.0590 | - | - | ||||||
Total Equity | 97.2000 | 130.1000 | 319.2000 | 235.2340 | 268.1733 | ||||||
Minority Interests | - | - | - | 102.4700 | 96.8640 | ||||||
Total liabilities equity | 154 | 185.7000 | 480.1000 | 490.2300 | 511.9940 |
Income Statement
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | .5000 | .4000 | .8000 | 1.0280 | .9884 | ||||||
Depreciation (total) | - | - | - | 16.0220 | 16.0304 | ||||||
Operating Result | -.8000 | -3.1000 | -5.2000 | -20.9820 | -20.3080 | ||||||
Interest Income | -.6000 | -.2000 | -.9000 | -.7190 | -1.0968 | ||||||
Income Before Taxes | 1 | 21.2000 | 53.2000 | - | - | ||||||
Income Taxes | 0.0000 | .0900 | -.0800 | -4.7390 | -4.7393 | ||||||
Minority Interests Profit | - | - | - | -5.5330 | -5.6061 | ||||||
Net Income | 1 | 21.1000 | 53.3000 | 14.3120 | 14.8793 |
Per Share
Cash Flow
|
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
2023 IFRS in mill. CHF |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -.4000 | -.4000 | -4.3000 | -4.6070 | .1718 | ||||||
Cash Flow from Investing Activities | -5.3000 | -3.9000 | -7 | -1.6840 | 1.0150 | ||||||
Cash Flow from Financing | 8.2000 | 6.4000 | 8.6000 | 4.5560 | .8286 | ||||||
Decrease / Increase in Cash | 2.5000 | 2.2000 | -2.8000 | - | - | ||||||
Employees | 2 | 6 | 13 | 13 | - |